arrow
S

Saman Maleki Vareki

Western University
H指数:28
被引数:3,793

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

通过血浆谱分析确定的癌症免疫治疗结果的代谢决定因素

2026-06-250
OAAI
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

粪便菌群移植联合免疫治疗非小细胞肺癌和黑色素瘤: fmt-luminate 2期临床试验

2026-01-280
OAAI
Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic Cancer

2025年加拿大全国胰腺大会:胰腺癌以患者为中心管理的最新进展

2026-01-010
OA
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development

Elkrief A, Pidgeon R, Maleki Vareki S, Messaoudene M, Castagner B, and Routy B. 肠道微生物组作为癌症免疫治疗的一个靶点:药物开发的机会与挑战。Nat Rev Drug Discov. (2025). doi: 10.1038/s41573-025-01211-7

2025-06-020
PRE
SITC strategic vision: prevention, premalignant immunity, host and environmental factors

SITC战略愿景:预防、癌前免疫、宿主和环境因素

2025-03-280
OA
Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)
2024-04-050
PRE
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial (vol 29, pg 2121, 2023 )

晚期黑色素瘤的粪便微生物群移植加anti-PD-1免疫疗法: I期试验 (第29卷,2121页,2023页)

2023-11-031
OA
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

晚期黑色素瘤的粪便菌群移植加anti-PD-1免疫治疗: I期试验

2023-07-06118
PRE